Abstract: A system for providing secondary data storage and recovery services for one or more networked host nodes has a server application for facilitating data backup and recovery services; at least one client application for facilitating host node configuration to receive services; a secondary data storage medium; and at least one mechanism for passive acquisition of data from the one or more host nodes for storage into the secondary data storage medium by the server application. In a preferred embodiment secondary storage is streamlined through continuous data backup and enhanced by elimination of redundant write data.

Abstract: Novel injectable depot compositions are provided comprising at least one active agent(s) optionally with one or more pharmaceutically acceptable excipient(s) in the form of a multi-component system preferably comprising at least two components which when administered to a subject in need thereof forms an in situ gel depot or implant at the site of injection upon contact with body fluids. Also described are process for preparation of such compositions and method of using such compositions.

Abstract: Hidden Markov Models (“HMMs”) are used to analyze keystroke dynamics measurements collected as a user types a predetermined string on a keyboard. A user enrolls by typing the predetermined string several times; the enrollment samples are used to train a HMM to identify the user. A candidate who claims to be the user provides a typing sample, and the HMM produces a probability to estimate the likelihood that the candidate is the user he claims to be. A computationally-efficient method for preparing HMMs to analyze certain types of processes is also described.

Abstract: The present invention relates to a nanosized electrochemical dispersion comprising essentially modified silica sol and at least one additive; also a process of preparing nanosized electrochemical dispersion, wherein the process comprises step of loading at least one additive to metalate modified silica sol to obtain the dispersion; in addition a rechargeable alkaline storage zinc battery comprising nanosized electrochemical dispersion consisting of essentially modified silica sol and at least one additive; further a method of manufacturing a rechargeable alkaline storage zinc battery, wherein the method comprises steps of adding a nanosized electrochemical dispersion consisting essentially modified silica sol and at least one additive into a conventional alkaline storage zinc battery to obtain a rechargeable alkaline storage zinc battery; and further a process to prevent dissolution of zinc in a battery, wherein the process comprises addition of nanosized aqueous electrochemical dispersion comprising essentia

Abstract: Service requests, which are used to properly process a network access request received from a client, are processed by routing the service requests between at least two service component instances according to a load balancing algorithm. Load balancing includes: calculating a first ticket amount and a second ticket amount; assigning the first ticket amount to a first instance and the second ticket amount to a second instance; using a selection scheme to select an instance having a ticket amount greater than a threshold amount to process a service request; decrementing the ticket amount corresponding to the instance selected; and scheduling the instance selected to receive a service request. The present invention may further include distinguishing between operable and inoperable instances, providing ticket amounts that are not based on performance ratings to inoperable instances, and providing ticket amounts that are based on performance ratings to operable instances.

Abstract: Disclosed are amide, thioamide, urea and thiourea compounds and compositions that inhibit soluble epoxide hydrolase (sEH), methods for preparing the compounds and compositions, and methods for treating patients with such compounds and compositions. The compounds, compositions, and methods are useful for treating a variety of sEH mediated diseases, including hypertensive, cardiovascular, inflammatory, and diabetic-related diseases.

Abstract: The present invention generally relates to methods useful for a therapy using a class of urea or amide compounds and related compositions, wherein the compound is a soluble epoxide hydrolase inhibitor, for treating and ameliorating the symptoms of diseases related to endothelial dysfunction.

Abstract: The present invention relates to a composition for a copious bloom of diatom algae comprising macro and or micro nutrients adsorbed on metalate modified silica sol. The present invention further relates to a process for preparing an aqueous dispersion of a composition comprising of iron adsorbed onto metalate modified silica sol containing 0.01% to 50% of Fe, and a micronutrient adsorbed onto metalate modified silica sol consisting of Mn, Zn, Co, Cu, Mo, B, V, Ni, Se, I, Fl, Cr, Cd and mixtures thereof in the proportion 0.001% to 30% of the weight of silica and macronutrient adsorbed onto metalate modified silica sol consisting of N, P, K, Mg, Ca, S, Cl, Na the elements of each macronutrient varying from 1% to 50% of the silica.

Abstract: Disclosed herein is a multi-cell battery pack having optimal temperature distribution throughout the battery pack and optimal air flow through the battery pack. Disclosed herein is a battery pack which provides optimal temperature distribution throughout the battery pack, wherein maximum cell temperature (Tmax) and temperature differential amongst all cells in the battery pack (?Tcell) are optimized for efficient thermal management providing safety, improved performance and extended life of the battery pack and electrochemical cells. Also disclosed herein is a battery pack which provides optimal flow through the battery pack and minimal pressure drop (?P) throughout the battery pack.

Abstract: A method and system for authenticated access to multicast traffic receives a request for a user to join a multicast channel. Access privileges of the user to the multicast channel are authenticated. The request is disallowed in response to at least an unsuccessful authentication.

Abstract: A method for handling access requests at multiple PoPs using the sharing of NAS information between the PoPs, enabling each PoP to maintain its own, independent, database of user records. When an access request is received, it is forwarded to a specific PoP designated as the user's “home PoP”. This home PoP is the only PoP to contain the user's records. The home PoP may then handle the access request by utilizing a local NAS list, the local NAS list being synchronized with other NAS lists in the network and providing information on all the “known” NASes throughout the entire network. This allows for a user to roam between PoPs, while reducing the bandwidth and security concerns that have existed in the past when users chose to roam. The NAS lists may then be updated via a central Network Control Console.

Abstract: Disclosed are heterocylic or heteroaryl compounds and compositions that inhibit soluble epoxide hydrolase (sEH), methods for preparing the compounds and compositions, and methods for treating patients with such compounds and compositions. The compounds, compositions, and methods are useful for treating a variety of sEH mediated diseases, including hypertensive, cardiovascular, inflammatory, pulmonary, and diabetic-related diseases.

Abstract: Disclosed are amide, thioamide, urea and thiourea compounds and compositions that inhibit soluble epoxide hydrolase (sEH), methods for preparing the compounds and compositions, and methods for treating patients with such compounds and compositions. The compounds, compositions, and methods are useful for treating a variety of sEH mediated diseases, including hypertensive, cardiovascular, inflammatory, and diabetic-related diseases.

Abstract: A method for conveying data communications network management information to an umbrella management system whereby network management information events are published on an information bus and received at a subscribing monitor interface located on the information bus. The monitor interface then converts the network management information events into umbrella management system-useable information and communicates the umbrella management useable information to the umbrella management system. In this manner, the umbrella management system is able to import valuable information pertaining to the devices and services that comprise the overall network. The monitor interface includes an adapter located on the information bus that subscribes to network management information events, a converter that formats the network management information events into data useable by the umbrella management system, and a forwarder that communicates the umbrella management system-useable data to the umbrella management system.

Abstract: An example of this presentation deals with the way the events emitted from a component can be grouped from the development phase, so that when the problem occurs in the production environment, the problem could be tracked easily and analyzed. The embodiment deals with the program having multiple separate paths for execution. The execution path could be the normal flow of events grouped together (and generating a key to represent the normal flow). The other execution paths could represent the alternate flows, also grouped, and a key is generated to represent which one is deviated from normal flow. The database stores the key and the relative event flow information, which indicates the grouped events. The lookup viewer can be provided for viewing the normal and alternate flows, since the event has been logged as keys. A “Key” is a hash on the static content of the events, which is used to identify a particular start and end of the functionality in a flow of execution.

Abstract: Disclosed are urea and thiourea compounds and compositions that inhibit soluble epoxide hydrolase (sEH), methods for preparing the compounds and compositions, and methods for treating patients with such compounds and compositions. The compounds, compositions, and methods are useful for treating a variety of sEH mediated diseases, including hypertensive, cardiovascular, inflammatory, and diabetic-related diseases.

Abstract: Disclosed are urea compounds, stereoisomer, or pharmaceutical acceptable salt thereof, and compositions that inhibit soluble epoxide hydrolase (sEH), methods for preparing the compounds and compositions, and methods for treating patients with such compounds and compositions. The compounds, compositions, and methods are useful for treating a variety of sEH mediated diseases, including hypertensive, cardiovascular, inflammatory, pulmonary, and diabetic-related diseases.

Abstract: Disclosed are urea compounds, stereoisomer, or pharmaceutical acceptable salt thereof, and compositions that inhibit soluble epoxide hydrolase (sEH), methods for preparing the compounds and compositions, and methods for treating patients with such compounds and compositions. The compounds, compositions, and methods are useful for treating a variety of sEH mediated diseases, including hypertensive, cardiovascular, inflammatory, pulmonary, and diabetic-related diseases.

Abstract: Disclosed are urea compounds of formula I, stereoisomer, or pharmaceutical acceptable salts thereof, and compositions that inhibit soluble epoxide hydrolase (sEH), methods for preparing the compounds and compositions, and methods for treating patients with such compounds and compositions. The compounds, compositions, and methods are useful for treating a variety of sEH mediated diseases, including hypertensive, cardiovascular, inflammatory, pulmonary, and diabetic-related diseases.

Abstract: Disclosed are alpha keto amide and alpha hydroxy amide compounds and compositions that inhibit soluble epoxide hydrolase (sEH), methods for preparing the compounds and compositions, and methods for treating patients with such compounds and compositions. The compounds, compositions, and methods are useful for treating a variety of sEH mediated diseases, including hypertensive, cardiovascular, inflammatory, pulmonary, and diabetic-related diseases.